API 0.00% $1.53 australian pharmaceutical industries limited

Ann: WES:Proposal to acquire Australian Pharmaceutical Industries, page-4

  1. 140 Posts.
    lightbulb Created with Sketch. 44
    Hi

    Interesting. Seems, IMO, to be a good deal for shareholders. WES management have a good record of creating good, long term returns. So a small increase in the bid price is a sound possibility. If, as is my case, you own both WES and API, then this looks like a rare win-win situation - realise a gain on API and retain, albeit diluted within WES, future EPS from API.

    Regards
    Old Fisherman
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.